Английская Википедия:CN v Secretary of State for Health and Social Care

Содержание

Текст

Текст

Текст

Текст

Текст

Текст

Текст

Текст

Текст

Шаблон:Short description Шаблон:Italic title Шаблон:Use dmy dates Шаблон:Infobox court case CN v Secretary of State for Health and Social Care [2022] EWCA Civ 86 was an appeal against the refusal of permission to apply for judicial review to challenge the infected blood supportШаблон:Efn scheme administered by the NHS Business Services Authority (NHSBSA) for non-inclusion of those infected with chronic Hepatitis B virus. The appeal was based on the grounds that the exclusion of those infected with HBV from the England Infected Blood Support Scheme (EIBSS) was unreasonable and discriminatory, contrary to article 14 when read in conjunction with article 8 and article 1 protocol 1 (A1P1) of the ECHR. The appellant also claimed that there was different treatment and that the failure to include those infected with HBV was unreasonable, and that the original application for review should not have been deemed out of time.

The permission appeal was unanimously dismissed because the application was deemed to be out of time and the claims under article 14 and the one based on unreasonableness and irrationality both failed. The court felt that the support scheme (EIBSS) was a response to a "pressing moral claim" and "an exception to the regime of fault based liability".

History of 'CN'

The appellant, known only as "CN", was infected with the hepatitis B virus which they believe to have contracted around the time of April 1989 at Hammersmith Hospital, where a blood transfusion was required during the course of a bone marrow transplant. Since being infected with HBV, CN experienced a number of serious health issues, including: chronic liver disease, renal failure, a compromised immune system, joint degeneration, Hypertension, short term memory loss, and breathlessness. CN had been running a successful catering business which had to be relinquished in order to seek medical treatment, and for the last 13 years, CN has had to be sustained by state benefits. In March 1995, CN had initiated litigation in the civil courts with the NHS and the National Blood Authority (NBA) as joint defendants, however the case was eventually discharged following the removal of public funding.

CN claimed to be in a "relevantly similar" position to beneficiaries infected with HIV and HCV who already came within the scope of support offered by the EIBSS, yet the scheme did not include infection with hepatitis B because blood donors were screened for hepatitis B from 1972, which meant that the likelihood of blood being contaminated with hepatitis B in the 1980s was far more remote than for infection with HIV and hepatitis C.

Detailed grounds

The appellant argued the appeal on four grounds:

1. that they were in a relevantly similar position to those infected with HIV and HCV
2. that the different treatment could not be justified by the Secretary of State
3. that it was unreasonable to fail to include those with HBV in the EIBSS scheme
4. that the judge should have extended time for the application to be made

Judgment

In dismissing the appeal, the court stated that it could not be said that CN was in a "relevantly similar position" since the proper comparison would need to be drawn with those who received blood or blood products which had not been screened and as a result were infected with Hepatitis C. Similarly, the other comparator group would be those who acquired HIV who would be unable to claim if the blood or blood products administered to them had been treated.

The Master of the Rolls argued that it was possible for the Secretary of State for Health and Social Care to reasonably justify a differential approach to treatment, especially where "economic policy" and decisions concerning disability were involved. The court maintained that the Secretary of State had to be afforded a broad "ambit of discretion" in setting up an ex gratia scheme such as EIBSS.

Delay

The refusal of permission to apply for judicial review was made on 15 February 2021 by Martin Spencer J on the basis that the application was "manifestly out of time". The non-inclusion of those infected with Hepatitis B was not considered a renewing act but an historic one, which can be pinpointed to the formation and alterations of the support schemes in 2004 and 2017. The court accepted that the limitation clock had started running with the inception of EIBSS on 1 November 2017.

See also

• A and Others v National Blood Authority and Another (Consumer law case involving claimants infected with hepatitis C)
• M.C. and Others v Italy (Right to property case involving bad blood victims)
• R (March) v Secretary of State for Health (UK judicial review quashing a decision on the grounds of material error of fact)